PlumX Metrics
Embed PlumX Metrics

Tumor diagnosis with new In-radioligands based on truncated human gastrin releasing peptide sequences: Synthesis and preclinical comparison

Journal of Medicinal Chemistry, ISSN: 0022-2623, Vol: 56, Issue: 21, Page: 8579-8587
2013
  • 13
    Citations
  • 0
    Usage
  • 10
    Captures
  • 0
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

Article Description

Radiolabeled analogs of the frog tetradecapeptide bombesin (BBN) have been proposed for diagnosis and therapy of gastrin releasing peptide receptor (GRPR)-expressing tumors. Following a different and yet unexplored approach, we have developed four novel In-labeled truncated analogs of the human 27-mer GRP after conjugation of 1,4,7,10-tetraazacyclododecane-1,4,7,10- tetraacetic acid (DOTA) at the N-terminus of GRP(13/14/17/18-27) fragments. Analog affinities for the human GRPR determined against [I- Tyr]BBN were at the nanomolar level and dependent on truncation site. The respective In radioligands specifically internalized in GRPR-expressing PC-3 cells. The shorter chain [In-DOTA]GRP(17/18- 27) analogs showed higher metabolic stability in mice. Radioligands specifically localized in human PC-3 xenografts in SCID mice, with [In-DOTA] GRP(17-27) exhibiting the most favorable pharmacokinetic profile. This study has demonstrated the efficacy of human GRP-based radiopeptides to target GRPR-positive lesions in vivo and has revealed the impact of GRP chain length on key biological parameters of resulting radiotracers. © 2013 American Chemical Society.

Bibliographic Details

Marsouvanidis, Panteleimon J; Maina, Theodosia; Sallegger, Werner; Krenning, Eric P; de Jong, Marion; Nock, Berthold A

American Chemical Society (ACS)

Biochemistry, Genetics and Molecular Biology; Pharmacology, Toxicology and Pharmaceutics

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know